News roundup - August 28 to September 10, 2020
Our faculty members frequently make appearences in the media as expert consultants or authors. Each week, we summarize some of the most recent media appearences and contributions our faculty have made.
New campaign aims to raise awareness on World Suicide Prevention Day
CTV News. September 10, 2020. Featuring Dr. Juveria Zaheer.
Dr. Juveria Zaheer speaks with CTV news about CAMH’s new “Not Suicide. Not Today.” Campaign. The campaign was launched on World Suicide Prevention Day on Sept. 10 and will feature empowering stories from real people who have suffered from mental illness, including addiction, and how they have recovered.
Older Canadians less likely to suffer depression despite increased COVID-19 death rate: study
Fort McMurray Today. September 10, 2020. Featuring Dr. Roger McIntyre.
Dr. Roger McIntyre discusses his recently published a “meta-analysis” of pandemic studies that concluded people under 40 and students are at particularly high risk for depressive symptoms during the COVID-19 pandemic.
Intra-Cellular Therapies News: Why ITCI Stock Is Skyrocketing 75% Today
InvestorPlace. September 9, 2020. Featuring Dr. Roger McIntyre.
Dr. Roger McIntyre explains the research findings that have resulted in a substantial increase in ITCI stock value.
Race, Religion And Mental Health: Therapy Should Be Culturally Relevant
Chatelaine. September 8, 2020. Featuring Dr. Yusra Ahmad and Dr. Farooq Naeem.
Dr. Yusra Ahmad and Dr. Farooq Naeem speak about the benefits of adapting therapy to the cultural experiences and views of patients.
Rural Journalists Deal with Mental-Health Toll Brought by Covid-19
The Daily Yonder. September 2, 2020. Featuring Dr. Anthony Feinstein.
Dr. Anthony Feinstein shares his findings regarding the stress journalists have experienced as a result of covering the pandemic.
Mississauga clinic to offer esketamine treatment to adults with major depressive disorder
GrowthOp. September 1, 2020. Featuring Dr. Roger McIntyre.
Dr. Roger McIntyre speaks about the benefits of Esketamine for patients suffering from depression.
Canadian clinical trial looks to acai berries in hopes of preventing severe cases of COVID-19
CTV News. August 30, 2020. Featuring Dr. Ana Andreazza.
Dr. Ana Andreazza’s previous studies have shown that the acai berry extract’s effect as a possible anti-inflammatory therapy for mental health disorders, which my be relevant to the treatment of severe COVID-19 cases.